Diabetes Clinical Trials in Massachusetts

Showing 461-480 of 610 trials

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

NCT02015806

The aim of this study is to determine whether adherence to oral maintenance medications differs for patients randomized to receive a RxTimerCap, a Take-N-Slide, a standard pillbox, or none of these devices, with the hypothesis that low-touch devices improve adherence over control and that the increase in adherence is agnostic across devices.

Cardiovascular DiseaseDiabetesBreast Cancer+5 more

Brigham and Women's Hospital53,480 participantsStarted Mar 2014

Woonsocket, Rhode Island, United States

TERMINATEDNA16 miles

Synchronization to Improve Non-Adherence to Cardiovascular Medications

NCT01963156

The aim of this study is to evaluate if synchronizing when patients with diabetes and/or coronary artery disease fill their prescriptions improves long-term adherence to these medications.

Chronic DiseaseCardiovascular DiseaseDiabetes Mellitus

Brigham and Women's Hospital3,675 participantsStarted Nov 2013

Woonsocket, Rhode Island, United States

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

Synchronization to Improve Non-Adherence to Cardiovascular Medications

Diabetes Trials in Other Cities

Retinal Blood Flow and Microthrombi in Type 1 Diabetes

Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns

e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions

Mobile Motivation for Health Promotion Among Adolescents

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Other Conditions in Massachusetts